Bibliography
- Banning M. Topical diclofenac: clinical effectiveness and current uses in osteoarthritis of the knee and soft tissue injuries. Expert Opin Pharmacother 2008;9:2921-9
- Zacher J, Altman R, Bellamy N, Topical diclofenac and its role in pain and inflammation: an evidence-based review. Curr Med Res Opin 2008;24:925-50
- Gallacchi G, Marcolongo R. Pharmacokinetics of diclofenac hydroxyethylpyrrolidine (DHEP) plasters in patients with monolateral knee joint effusion. Drugs Exp Clin Res 1993;19:95-7
- Assandri A, Canali S, Giachetti C. Local tolerability and pharmacokinetic profile of a new transdermal delivery system, diclofenac hydroxyethylpyrrolidine plaster. Drugs Exp Clin Res 1993;19:89-95
- Predel HG, Koll R, Pabst H, Diclofenac patch for topical treatment of acute impact injuries: a randomised, double blind, placebo controlled, multicentre study. Br J Sports Med 2004;38:318-23
- Gschwend MH, Martin W, Arnold P, Determination of the transdermal bioavailability of a newly developed diclofenac sodium patch in comparison with a reference preparation. Arzneimittelforschung 2005;55:403-13
- Committee for Medicinal Products for Human Use (CHMP). Guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis. CPMP/EWP/784/97 Rev 1, 23 April 2009 (Draft). Available from: http://www.emea.europa.eu/pdfs/human/ewp/078497endraft.pdf [Last accessed 28 September 2009]
- Huskisson EC. Measurement of pain. Lancet 1974;2:1127-31
- Huskisson EC. Measurement of pain. J Rheumatol 1982;9:768-9
- Maurer W, Hothorn LA, Lehmacher W. Multiple comparisons in drug clinical trials and preclinical assays: a-priori ordered hypotheses. In: Vollmar J, editor, Biometrie in der chemisch-pharmazeutischen Industrie. Band 6. Stuttgart, Gustav Fischer Verlag; 1995. p. 3-18
- Mason L, Moore RA, Edwards JE, Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract 2004;5:10
- Galer BS, Rowbotham M, Perander J, Topical diclofenac patch relieves minor sports injury pain: results of a multicenter controlled clinical trial. J Pain Symptom Manage 2000;19:287-94
- Schermer R. Topical therapy for sprains of the ankle joint. A double-blind study of the efficacy of diclofenac-diethylammonium in an emulsion-gel. Wehrmed Mschr 1991;9:415-17
- Petersen B, Rovati S. Diclofenac epolamine (Flector®) patch: evidence for topical activity. Clin Drug Investig 2009;29:1-9
- Rainsford KD, Kean WF, Ehrlich GE. Review of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamine. Curr Med Res Opin 2008;24:2967-92
- Kelly AM. Does the clinically significant difference in visual analog scale pain scores vary with gender, age, or cause of pain? Acad Emerg Med 1998;5:1086-90
- Ehrich EW, Davies GM, Watson DJ, Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol 2000;27:2635-41
- Tubach F, Ravaud P, Baron G, Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis 2005;64:29-33
- Bjordal JM, Klovning A, Ljunggren AE, Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials. Eur J Pain 2007;11:125-38
- Moore RA, Moore OA, Derry S, Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Ann Rheum Dis 2009: published online 12 April 2009, doi: 10.1136/ard.2009.107805
- Heyneman CA. Topical nonsteroidal antiinflammatory drugs for acute soft tissue injuries. Ann Pharmacother 1995;29:780-2